[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us

Technology in Health and the emergence of Apple

by Jackie (née Heneghan) Peck | Jun 12, 2014 | Behind the scenes, Blog, Regulation

It was announced earlier this month that Apple were launching their own healthcare and fitness app called HealthKit.  The app is part of iOS8 and has the potential to communicate patient health data to hospitals and clinicians. The idea behind all of this is...

Online Pharmacy – are patients better with a ‘face to face’?

by Jackie (née Heneghan) Peck | Jun 12, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Regulation

Recent coverage in the Australian community pharmacy press has centred around the benefit and/or potential harm of prescribing and dispensing medicines without a face-to-face consultation.  The discussion raised asked the question whether an online questionnaire is...

RP & GDP Training for WDA(H)

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation

RP – Responsible Person relating to MHRA GDP – Good Distribution Practice – the guidelines by which medicine wholesalers must adhere to WDA(H) – Wholesale Distribution Authorisation for Human Use – previously Wholesale Dealer’s...

Out of Specification (OOS) Test Results

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Pharmacy Suppliers, Regulation

What are Out of Specification results (OOS)?  It seems to be clear enough in the name but I thought I better check it out. One definition is: All test results which fall outside the specifications or acceptance criteria established in drug applications, drug master...

Quality Agreements- Technical Agreements- Good ones are invaluable!

by Jackie (née Heneghan) Peck | May 12, 2014 | Blog, Pharmacy Brands, Pharmacy Suppliers, Regulation

TAs – when do we need them in place and who with and what should be in them? PCL have been reviewing a few TAs over the last few weeks and we have put a few tips and hints together. If you only follow GDP or GMP; the principals are the same. If you are a...

The current state of Pfizer

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation

Pfizer’s bid for AstraZeneca scrutinised – should it be only the shareholders who decide? AstraZeneca employs over six thousand people in the UK. Pfizer has made nine promises in a letter to David Cameron which are said to reflect Pfizer’s commitment to the UK....
« Older Entries
Next Entries »

Recent Posts

  • What are the main requirements for controlled drugs?
  • FSN for Zoll Powerheart G5 AEDs
  • Virtual Wholesaling

Upcoming Courses

  • RP Forum – Inspection Preparation and RP Readiness on 8 July 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 15 July 2025
  • GDP Audit Online Training on 17 July 2025 10:00 am
  • Introduction to Good Distribution Practice Online Training on 23 July 2025 10:00 am
  • Export Online Training on 7 August 2025

MHRA Alerts & Recalls

Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets, Wockhardt UK Ltd, EL(25)A/31
30 June 2025
Class 3 Medicines Recall: Omeprazole 20 mg/15 ml Oral Solution, Glenmark Pharmaceuticals Europe Ltd, EL(25)A/30
30 June 2025
Class 2 Medicines Recall: Depo-Medrone 80 mg in 2 mL, Maxearn Limited EL(25)A/29
25 June 2025
Class 3 Medicines Recall: Kimmtrak 200 micrograms/mL concentrate for solution for infusion, Immunocore Limited, EL(25)A/28
25 June 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow